Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Jade Biosciences to Participate in Two Upcoming Investor Conferences
-
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
-
Jade Biosciences Presents JADE101 Preclinical Data at 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgAN
-
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
-
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
-
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
-
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit
-
Jade Biosciences to Participate in Upcoming Investor Conferences
-
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement